The Russian consensus on the diagnosis and treatment of chronic pancreatitis has been prepared on the initiative of the Russian Pancreatology Club to clarify and consolidate the opinions of Russian specialists (gastroenterologists, surgeons, and pediatricians) on the most significant problems of diagnosis and treatment of chronic pancreatitis. This article continues a series of publications explaining the most significant interdisciplinary consensus statements and deals with enzyme replacement therapy

Abdulkhakov S.

Alekseenko S.

Alieva E.

Alikhanov R.

Bakulin I.

Baranovsky A.

Beloborodova E.

Belousova E.

Bordin D.

Buriev I.

Bystrovskaya E.

Danilov M.

Darvin V.

Dubtsova E.

Dyuzheva T.

Efanov M.

Egorov V.

Galperin E.

Gorelov A.

Grinevich V.

Ivashkin V.

Izrailov R.

Khatkov I.

Kokhanenko N.

Kornienko E.

Korobka V.

Korochanskaya N.

Kucheryavyi Y.

Livzan M.

Loranskaya I.

Maev I.

Nikolskaya K.

Okhlobystin A.

Osipenko M.

Pasechnikov V.

Plotnikova E.

Polyakova S.

Sablin O.

Shabunin A.

Simanenkov V.

Tsukanov V.

Tsvirkun V.

Ursova N.

Vertyankin S.

Vinokurova L.

Zagainov V.

Zakharova N.

Terapevticheskii arkhiv

Kazan Federal University Digital Repository

Terapevticheskii Arkhiv 2017 vol.89 N8, pages 80-87The Russian consensus on the diagnosis and treatmentof chronic pancreatitis: Enzyme replacement therapyKhatkov I., Maev I., Bordin D., Kucheryavyi Y., Abdulkhakov S., Alekseenko S., Alieva E.,Alikhanov R., Bakulin I., Baranovsky A., Beloborodova E., Belousova E., Buriev I., BystrovskayaE., Vertyankin S., Vinokurova L., Galperin E., Gorelov A., Grinevich V., Danilov M., Darvin V.,Dubtsova E., Dyuzheva T., Egorov V., Efanov M., Zakharova N., Zagainov V., Ivashkin V., IzrailovR., Korochanskaya N., Kornienko E., Korobka V., Kokhanenko N., Livzan M., Loranskaya I.,Nikolskaya K., Osipenko M., Okhlobystin A., Pasechnikov V., Plotnikova E., Polyakova S., SablinO., Simanenkov V., Ursova N., Tsvirkun V., Tsukanov V., Shabunin A.Kazan Federal University, 420008, Kremlevskaya 18, Kazan, RussiaAbstractThe  Russian  consensus  on  the  diagnosis  and  treatment  of  chronic  pancreatitis  has  beenprepared on the initiative of the Russian Pancreatology Club to clarify and consolidate theopinions of Russian specialists (gastroenterologists, surgeons, and pediatricians) on the mostsignificant problems of diagnosis and treatment of chronic pancreatitis. This article continues aseries of publications explaining the most significant interdisciplinary consensus statements anddeals with enzyme replacement therapy.http://dx.doi.org/10.17116/terarkh201789880-87KeywordsChronic pancreatitis, Consensus, Diagnosis, Enzyme replacement therapy, TreatmentReferences[1] L i n s t one  H ,  T u r o f f  M .  T he  De l ph i  me thod :  T e chn i que s  and  app l i c a t i o n s .  URL :http: / /www. is .n j i t .edu/pubs/delphibook/[2] Khatkov IE, Maev IV, Abdulkhakov SR, et al. The Russian consensus on the diagnosis and treatment of chronicp a n c r e a t i t i s .  T e r a p e v t i c h e s k i j  a r k h i v .  2 0 1 7 ; 8 9 ( 2 ) : 1 0 5 - 1 1 3 .  ( I n  R u s s . ) .https: / /doi .org/10.17116/terarkh2017892105-113[3] Khatkov IE, Maev IV, Bordin DS, Kucheryavyy YuA et al. The Russian consensus on diagnostics and treatment ofchronic pancreatitis: emphasis on the nutritive status and diet questions. Farmateka. 2016;S5-16:27-32. (InRuss.).[4] Khatkov IE, Maev IV, Bordin DS, Kucheryavyy YuA et al. Controversial issues of the Russian consensus ondiagnostics and treatment of chronic pancreatitis. Almanah clin. mediciny. 2016; 44(6):654-660. (In Russ.).[5] Khatkov IE, Maev IV, Bordin DS, Kucheryavyy YuA et al. Russian consensus on the diagnosis and treatment ofchronic pancreatitis: treatment of abdominal pain. Doctor.Ru. 2017;2(131):38-45. (In Russ.).[6] Recommendations of the Russian Scientific Society of Gastroenterologists on the diagnostics and treatment ofchronic pancreatitis (adopted at the 11th Congress of the RSSG, March 2, 2011, at the meeting of RussianPancreatic Club). Experimental and clinical gastroenterology 2011;7:122-129. (In Russ.).[7] Maev I V, Kucheryavyy YuA, Andreev DN, Bideeva TV. Nutritional status in patients with chronic pancreatitis.Terapevticheskij arkhiv. 2016;88(2):81-89. (In Russ.). https://doi.org/10.17116/terarkh201688281-89[8] Hart  PA,  Conwell  DL.  Diagnosis  of  Exocrine  Pancreatic  Insufficiency.  Curr  Treat  Options  Gastroenterol.2015;13(3):347-353. https://doi.org/10.1007/s11938-015-0057-8[9] Dumasy  V,  Delhaye  M,  Cotton  F,  Deviere  J.  Fat  malabsorption  screening  in  chronic  pancreatitis.  Am JGastroenterology. 2004;99: 1350-1354. https://doi.org/10.1111/j.1572-0241.2004.30661.x[10] Bornman PC, Botha JF, Ramos JM et al. Guideline for the diagnosis and treatment of chronic pancreatitis. S AfrMed J. 2010; 100(12 Pt 2):845-860.[11] Conwell DL, Lee LS, Yadav D et al. Daniel S. American Pancreatic Association Practice Guidelines in ChronicPancreatitis  Evidence-Based  Report  on  Diagnostic  Guidelines.  Pancreas.  2014;43(8):1143-1162https://doi.org/10.1097/MPA.0000000000000237[12] Trang T, Chan J, Graham DY. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency inthe 21st century. World J Gastroenterol. 2014;20(33):11467-11485. https://doi.org/10.3748/wjg.v20.i33.11467[13] Afghani  E1,  Sinha  A,  Singh  VK.  An  overview of  the  diagnosis  and  management  of  nutrition  in  chronicpancreatitis. Nutr Clin Pract. 2014;29(3):295-311. https://doi.org/10.1177/0884533614529996[14] Toouli  J,  Biankin  AV,  Oliver  MR,  Pearce  CB,  Wilson  JS,  Wray  NH.  Management  of  pancreatic  exocrineinsufficiency: Australasian Pancreatic Club recommendations. Med J Aust. 2010; 193:461-467.[15] Lohr JM,  Oliver MR, Frulloni  L.  Synopsis  of  recent guidelines on pancreatic  exocrine insufficiency.  UnitedEuropean Gastroenterology Journal. 1(2):79-83. https://doi.org/10.1177/2050640613476500[16] Dominguez-Munoz JE, Iglesias-Garcia J, Vilarino-Insua M, et al. 13C-mixed triglyceride breath test to assess oralenzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2007;5:484-488.https://doi.org/10.1016/j.cgh.2007.01.004[17] Lindkvist B, Phillips ME, Dominguez-Munoz JE. Clinical, anthropometric and laboratory nutritional markers ofpancreatic  exocrine  insufficiency:  Prevalence  and  diagnostic  use.  Pancreatology.  2015;15(6):589-597.https://doi.org/10.1016/j.pan.2015.07.001[18] De-Madaria E, Abad-Gonzalez A, Aparicio JR. et al. The Spanish Pancreatic Club's recommendations for thediagnosis  and  treatment  of  chronic  pancreatitis:  part  2(treatment).  Pancreatology.  2013;13:18-28.https://doi.org/10.1016/j.pan.2012.11.310[19] Maev IV, Kucheryavyy YuA. Replacement enzyme therapy in pancreatic insufficiency. Clinical perspectives ofgastroenterology, hepatology. 2005;5:19-28. (In Russ.).[20] Ivashkin VT, Maev IV, Okhlobystin AV, Kucheryavyy YA, Trukhmanov AS, Sheptulin AA, Shifrin OS, Lapina TL,Osipenko MF, Simanenko VI,  Khlynov IB,  Alekseenko SA, Alekseeva OP, Chikunova MV. guidelines of  theRussian  gastroenterological  Association  on  diagnostics  and  treatment  of  chronic  pancreatitis.  Russianmagazine. of gastroenterology., gepatol., koloproktol. 2014;4:70-97. (In Russ.).[21] Hoffmeister A, Mayerle J, Beglinger C, Buchler MW, Bufler P, Dathe K, Folsch UR, Friess H, Izbicki J, Kahl S, KlarE, Keller J, Knoefel WT, Layer P, Loehr M, Meier R, Riemann JF, Runzi M, Schmid RM, Schreyer A, Tribl B, WernerJ,  Witt  H,  Mossner  J,  Lerch  M.  S3-Leitlinie  Chronische  Pankreatitis:  Definition,  Atiologie,  Diagnostik,konservative, interventionell endoskopische und operative Therapie der chronischen Pankreatitis. Leitlinie derDeutschen  Gesellschaft  fur  Verdauungsund  Stoffwechselkrankheiten  (DGVS).  Z  Gastroenterol.2012;50(11):1176-1224.  https://doi.org/10.1055/s-0032-1325479[22] Frulloni L, Falconi M, Gabbrielli A, Gaia E, et al. Italian consensus guidelines for chronic pancreatitis. Dig LiverDis. 2010;42(Suppl. 6): S381-406. https://doi.org/10.1016/S1590-8658(10)60682-2[23] Halm U, Löser C, Lohr M, et al. A double-blind, randomized, multicentre, crossover study to prove equivalenceof pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment PharmacolTher. 1999;13(7):951-957.[24] Dominguez-Munoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep.2007;9:116-122.[25] Bruno MJ, Rauws EA, Hoek FJ, Tytgat GN. Comparative effects of adjuvant cimetidine and omeprazole duringpancreatic enzyme replacement therapy. Dig Dis Sci. 1994;39(5):988-992.[26] Sander-Struckmeier S, Beckmann K, Janssen-van Solingen G, Pollack P. Retrospective analysis to investigatethe  effect  of  concomitant  use  of  gastric  acid-suppressing  drugs  on  the  efficacy  and  safety  ofpancrelipase/pancreatin (CREON) in patients with pancreatic exocrine insufficiency. Pancreas. 2013;42(6):983-989. https://doi.org/10.1097/MPA.0b013e31828784ef[27] Vecht J, Symersky T, Lamers CB, Masclee AA. Efficacy of lower than standard doses of pancreatic enzymesupplementation  therapy  during  acid  inhibition  in  patients  with  pancreatic  exocrine  insufficiency.  J  ClinGastroenterol. 2006;40:721-725.[28] Dominguez-Munoz JE. Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes?Clin Gastroenterol Hepatol. 2011;9(7):541-546. https://doi.org/10.1016/j.cgh.2011.02.027[29] Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H. Randomised clinical trial: a 1-week, double-blind,placebocontrolled study of pancreatin 25 000 Ph. Eur. Minimicrospheres (Creon 25000 MMS) for pancreaticexocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Aliment Pharmacol Ther.2013;37(7):691-702. https://doi.org/10.1111/apt.12236[30] Sikkens EC, Cahen DL, Kuipers EJ, Bruno MJ. Pancreatic enzyme replacement therapy in chronic pancreatitis.Best Pract Res Clin Gastroenterol. 2010;24(3):337-347. https://doi.org/10.1016/j.bpg.2010.03.006[31] Bordin D, Vinokurova L, Dubtsova E, Osipenko Yu. Chronic pancreatitis and the syndrome of excessive bacterialgrowth. Vrach. 2011;13:5-10. (In Russ.).[32] Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future.Clin Exp Gastroenterol. 2011;4:55-73. https://doi.org/10.2147/CEG.S17634[33] Quian Z, Fields CJ, Yu Y, Lutz S. Recent progress in engineering alpha/beta hydrolase-fold family members.Biotechnol J. 2007; 2(2):192-200.[34] Gheorghe C, Seicean A, Saftoiu A, Tantau M, Dumitru E, Jinga M, Negreanu L, Mateescu B, Gheorghe L,Ciocirlan M, Cijevschi C, Constantinescu G, Dima S, Diculescu M. Romanian Guidelines on the Diagnosis andTreatment  of  Exocrine  Pancreatic  Insufficiency.  J  Gastrointestin  Liver  Dis.  2015;24(1):117-123.https://doi.org/10.15403/jgld.2014.1121.app[35] Ramesh H, Reddy N, Bhatia S, etal. A 51-week, open-label clinical trial in India to assess the efficacy and safetyof pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due tochronic pancreatitis. Pancreatology. 2013;13:133-139. https://doi.org/10.1016/j.pan.2013.01.009[36] Whitcomb DC, Lehman GA, Vasileva G et al.  Pancrelipase delayedrelease capsules (CREON) for exocrinepancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A doubleblind randomized trial. Am JGastroenterol. 2010;105:2276-2286. https://doi.org/10.1038/ajg.2010.201[37] Somaraju UR, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis. CochraneDatabase Syst Rev. 2014;10:CD008227. https://doi.org/10.1002/14651858.CD008227.pub2[38] Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G, Falconi M, Frulloni L. Exocrine pancreaticinsufficiency in adults: A shared position statement of the Italian association for the study of the pancreas; theExocrine Pancreatic Insufficiency collaborative (EPIc) Group. World J Gastroenterol. 2013;19(44): 7930-7946.https://doi.org/10.3748/wjg.v19.i44.7930[39] Bansi DS, Price A, Russell C, Sarner M. Fibrosing colonopathy in an adult owing to over use of pancreaticenzyme supplements. Gut. 2000;46(2):283-285.[40] Prescott  P,  Bakowski  MT.  Pathogenesis  of  fibrosing colonopathy:  the role of  methacrylic  acid copolymer.Pharmacoepidemiol Drug Saf. 1999;8(6):377-384. https://doi.org/10.1002/(SICI)1099-1557(199910/11)8:6377::AID-PDS448>3.0.CO;2-C[41] Sack J, Blau H, Goldfarb D, Ben-Zaray S, Katznelson D. Hyperuricosuria in cystic fibrosis patients treated withpancreatic enzyme supplements. A study of 16 patients in Israel. Isr J Med Sci. 1980;16:417-419.[42] Ewald N, Kaufmann C, Raspe A, et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type3c). Diabetes Metab Res Rev. 2012;28(4):338-342. https://doi.org/10.1002/dmrr.2260[43] Weitgasser R, Abrahamian H, Clodi M, Fortunat W, Hammer H. Position paper: Exocrine pancreatic insufficiencyand diabetes mellitus. Wien Klin Wochenschr. 2012;124(Suppl.2):100-103. https://doi.org/10.1007/s00508-01--0290-2[44] Maev IV, Kucheryavyy YuA, Moskaleva AB. Chronic pancreatitis: myths and realities. Pharmateka. 2010;12:24-31. (In Russ.).[45] Frulloni L, Falconi M, Gabbrielli A et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis.2010;42(suppl. 6):381-406. https://doi.org/10.1016/S1590-8658(10)60682-2

The Russian consensus on the diagnosis and treatment of chronic pancreatitis: Enzyme replacement therapy

http://dspace.kpfu.ru/xmlui/bitstream/net/129572/-1/SCOPUS00403660-2017-89-8-SID85030449492-a1.pdf

The Russian consensus on the diagnosis and treatment of chronic pancreatitis: Enzyme replacement therapy

Abstract

Similar works

Full text

Available Versions

Kazan Federal University Digital Repository